RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,403 | -30.9% | 8,608,946 | +3.2% | 0.01% | -26.7% |
| Q2 2023 | $104,820 | -7.3% | 8,345,517 | +21.6% | 0.02% | -11.8% |
| Q1 2023 | $113,034 | +68.4% | 6,862,960 | +52.7% | 0.02% | +54.5% |
| Q4 2022 | $67,126 | -99.9% | 4,493,004 | -1.5% | 0.01% | -35.3% |
| Q3 2022 | $102,039,000 | +14.9% | 4,561,363 | -13.9% | 0.02% | +54.5% |
| Q2 2022 | $88,780,000 | -40.7% | 5,300,307 | +6.0% | 0.01% | -26.7% |
| Q1 2022 | $149,642,000 | +17.3% | 4,999,718 | +20.3% | 0.02% | +36.4% |
| Q4 2021 | $127,611,000 | +150.1% | 4,155,341 | +156.8% | 0.01% | +120.0% |
| Q3 2021 | $51,014,000 | +18.8% | 1,617,953 | +37.9% | 0.01% | +25.0% |
| Q2 2021 | $42,938,000 | -17.5% | 1,173,482 | -22.0% | 0.00% | -20.0% |
| Q1 2021 | $52,031,000 | +61.8% | 1,505,092 | +94.6% | 0.01% | +66.7% |
| Q4 2020 | $32,150,000 | -4.1% | 773,575 | -1.8% | 0.00% | -25.0% |
| Q3 2020 | $33,540,000 | – | 787,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |